Home→Healthcare Professionals

Overview for Healthcare Professionals on Anaphylaxis and Allergy Management

This section offers an in-depth guide for healthcare professionals in the UK, focusing on the diagnosis, treatment, and ongoing management of anaphylaxis and allergies.

diagnosing allergy and anaphylaxis

NICE Quality Standards and Guidelines

The NICE guidelines on food allergies and anaphylaxis provide detailed recommendations for the diagnosis, management, and long-term care of individuals, particularly children and young people, at risk of allergies and anaphylaxis.
Adrenaline (epinephrine) is the emergency treatment for a serious allergic reaction.

Adrenaline and Auto-Injectors (AAIs)

Healthcare professionals are encouraged to familiarise themselves with these guidelines to ensure patients at risk of anaphylaxis are prescribed and properly equipped to manage emergency situations.
Making an Allergy Management Plan

Allergy Management Plans

The Royal College of Paediatrics and Child Health (RCPCH) and the British Society for Allergy & Clinical Immunology (BSACI) provide essential resources for managing anaphylaxis and allergies in children.

Free downloadable posters

See our free posters

AllergyWise for Healthcare Professionals

AllergyWise® is an online e-learning course and the easiest way to learn about anaphylaxis, the risks of serious allergies and how to manage them. The courses can be worked through conveniently from your home or workplace, wherever and whenever it suits you. The courses are simple to follow with interactive diagrams and graphics which makes learning about anaphylaxis and teaching those around you easier than ever, no matter who you are or what you do.

New international consensus report on anaphylaxis management released 21st March 2025

A new consensus report on anaphylaxis has been published in The Journal of Allergy and Clinical Immunology by the Global Allergy and Asthma Excellence Network (GA2LEN). This report, developed by an international panel of 46 experts from 14 countries, addresses

Read more
Real-world safety of allergen immunotherapy in adults with respiratory allergies 21st March 2025

A recent study published in Allergy examined real-world safety data on allergen immunotherapy (AIT) in adults with respiratory allergies. The study followed 1,545 patients—using both sublingual (SLIT) and subcutaneous (SCIT) routes—across eight European countries. Adverse events were recorded in 7.4% of patients,

Read more
New review highlights potential of epicutaneous immunotherapy for food allergies 21st March 2025

A new systematic review published in Clinical and Translational Allergy examines the potential of epicutaneous immunotherapy (EPIT) for treating food allergies. The study, conducted by researchers from Tampere University and Imperial College London, analysed data from 11 randomised controlled trials

Read more

Latest News for Healthcare Professionals

New adrenaline patch for allergic reactions moves closer to approval in America  10th July 2025

Anaphylm is a medicine being developed by Aquestive Therapeutics for the emergency treatment of serious allergic reactions, including anaphylaxis.
[…]

Read more
Get involved in research: are you a parent or caregiver of an infant aged 0-17 weeks? 27th June 2025

Researchers at the University of Southampton are inviting parents and caregivers of young infants to take part in a research study to help prevent food allergy in babies. This research is part of a doctorate project led by Karen Wright,
[…]

Read more
New study reveals rising cashew nut allergy in children and unexpected almond allergy risk in adults 24th June 2025

A new study using data from the European Anaphylaxis Registry has identified important changes in which tree nuts are most likely to cause serious allergic reactions (anaphylaxis) in children and adults across Europe. The results show that cashew nuts are
[…]

Read more
Subscribe to our free monthly newsletter for healthcare professionals